Andere Sprachen Diaceutics PLC

Aktien

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:17 26.04.2024			% 5 Tage	% 1. Jan.
103 ^GBX	0.00%		-0.48%	+18.39%

02.04.	Roadside-Aktien ausgesetzt; Adnams sucht nach Geldmitteln	AN
21.03.	Diaceutics verbessert die Plattform für die Vermarktung von Diagnostika, DXRX	AN

Roadside shares suspended; Adnams looks for funds	02.04.
Diaceutics upgrades diagnositc commercialisation platform, DXRX	21.03.
Diaceutics PLC Launches Significant Upgrade to Its DXRX Platform	21.03.
Sondrel wins USD23 million contract	27.02.
Diaceutics Expands Lab Network, Data Coverage in Europe	27.02.
Diaceutics announces new marketing partnership with KPMG	14.02.
Diaceutics maintains "momentum" for year ahead on revenue rise in 2023	30.01.
Diaceutics revenue grows but loss widens, CEO Keeling to step down	26.09.23
Diaceutics Announces Executive Changes	26.09.23
Diaceutics CEO to Resign; Chief Innovation Officer Named Successor	26.09.23
Earnings Flash (DXRX.L) DIACEUTICS Posts H1 Revenue GBP9.9M	26.09.23
Diaceutics PLC Reports Earnings Results for the Half Year Ended June 30, 2023	26.09.23
Diaceutics PLC Announces Executive Changes, Effective 1 October 2023	21.09.23
Diaceutics launches daily alerts for DXRX platform	29.08.23
Diaceutics plc Launches Daily Alerts for Dxrx Platform	29.08.23
Diaceutics interim revenue jumps as order book grows to GBP24 million	25.07.23
Diaceutics PLC Announces Revenue Results for the Six Months Ended 30 June 2023	25.07.23
Diaceutics shares surge on contract win with top US firm	05.06.23
AIM WINNERS & LOSERS: Tristel hails FDA approval of ULT disinfectant	05.06.23
Diaceutics Up 13% Following Three-year Enterprise Contract With Global Pharma Company	05.06.23

Keine Ergebnisse zu dieser Suche